The preventive effect of low molecular weight heparin on CCL4-induced necrosis and apoptosis in rat liver

Annals of Hepatology

Volumn 9, Issue 4, 2010, Pages 445-454

  Kukner, Aysel ^a   Tore, Fatma ^a   Firat, Tülin ^a   Terzi, E Hakan ^a   Oner, Hakan ^b   Balaban, Yasemin H ^c   Ozogul, Candan ^d  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b Mehmet Akif University   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; CCl4; Enoxaparin; Liver; PCNA

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; CYCLINE; ENOXAPARIN; ENTACTIN; FAT DROPLET; LOW MOLECULAR WEIGHT HEPARIN; ACTIN; CARBON TETRACHLORIDE; COLLAGEN; FIBRINOLYTIC AGENT; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LIVER CELL; LIVER HISTOLOGY; LIVER INJURY; LIVER NECROSIS; LIVER REGENERATION; MALE; MAST CELL; NICK END LABELING; NONHUMAN; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; LIVER; METABOLISM; NECROSIS; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXIC HEPATITIS;

ACTINS; ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CASPASE 3; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; LIVER; MALE; MEMBRANE GLYCOPROTEINS; NECROSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79952307115     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
2. Palmes D, Spiegel HU. Animal models of liver regeneration. Biomaterials 2004; 25: 1601-1611.
3. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic Fibrosis: Molecular Mechanisms and Drug Targets. Annu Rev Pharmacol Toxicol 2005; 45: 605-628.
4. + exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. J Hepatol 1999; 30: 868-875.
5. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153: 515-525.
6. Park SW, Lee CH, Kim YS, Kang SS, Jeon SJ, Son KH, Lee SM. Protective Effect of Baicalin Against Carbon Tetra-chloride-Induced Acute Hepatic Injury in Mice. J Pharmacol Sci 2008;106:136-143.
7. Liu J, Tan H, Sun Y, Zhou S, Cao J, Wang F. The preventive effects of heparin-superoxide dismutase on carbon tetra-chloride-induced acute liver failure and hepatic fibrosis in mice. Mol Cell Biochem 2009; 327: 219-228.
8. Abe W, Ikejima K, Lang T, Okumura K, Enomoto N, Kitamu-ra T, Takei Y, et al. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol 2007; 46: 286-294.
9. Lee JI, Lee KS, Paik YH, Park YN, Han KH, Chon CY, Moon YM. Apoptosis of hepatic stellate cells in carbon tetra-chloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J Hepatol 2003; 39: 960-966.
10. Matsumoto K, Nakamura T. Heparin functions as a hepato-trophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun 1996; 227: 455-461.
11. Sakiyama R, Fukuta K, Matsumoto K, Furukawa M, Taka-hashi Y, Nakamura T. Stimulation of Hepatocyte Growth Factor Production by Heparin-derived Oligosaccharides. J Biochem 2007; 141: 653-660.
12. Tore F, Tuncel N. Mast cells: target and source of neuro-peptides. Curr Pharm Des 2009; 15: 3433-3445.
13. Jeong DH, Lee GP, Jeong WI, Do SH, Yang HJ, et al. Alterations of mast cells and TGF-β1 on the silymarin treatment for CCl4- induced hepatic fibrosis. World J Gastroenterol 2005; 11: 1141-1148.
14. Matsunaga Y, Kawasaki H, Terada T. Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis. Am J Gastroenterol 1999; 94: 1923-1932.
15. Takeshita A, Shibayama Y. Role of mast cells in hepatic remodeling during cholestasis and its resolution: relevance to regulation of apoptosis. Exp Toxicol Pathol 2005; 56: 273-280.
16. Abraham P, Cathrine WG. Oxidative damage to the lipids and proteins pf the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clin Chim Act 1999; 289: 177-179.
17. Fýrat T, Kükner A, Töre F, Ergür BU. The effect of low molecular weight heparin on kidney tissue of rats exposed to carbon tetrachloride. Erciyes Medical J 2009; 31: 293-303.
18. Wernke MJ, Schell JD. Solvent and malignancy. Clin Occup Environ Med 2004; 4: 513-527.
19. Das RK, Hossain U, Bhattacharya S. Protective effect of diphenylmethyl selenocyanate against CCl4-induced hepatic injury. J Appl Toxicol 2007; 27: 527-537.
20. Rivera-Espinoza Y, Muriel P. Pharmacological actions of curcumin in liver diseases or damage. Liver Int 2009; 29: 1457-1466.
21. Priya S, Sudhakaran PR. Curcumin-induced recovery from hepatic injury involves induction of apoptosis of activated hepatic stellate cells. Indian J Biochem Biophys 2008; 45: 317-325.
22. Deepa PR, Varalakshmi P. The cytoprotective role of a low-molecular-weight heparin fragment studied in an experimental model of glomerulotoxicity. Eur J Pharmacol 2003; 478; 199-205.
23. Günther A, Lübke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, et al. Prevention of bleomy-cin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med. 2003; 168: 1358-1365.
24. Tsukada S, Enomoto N, Takei Y, Hirose M, Ikejima K, Kita-mura T, Sato N. Dalteparin sodium prevents liver injury due to lipopolysaccharide in rat through suppression of tumor necrosis factor-alpha production by Kupffer cells. Alcohol Clin Exp Res 2003; 27: 7-11.
25. Assy N, Hussein O, Khalil A, Luder A, Szvalb S, Paizi M, Spi-ra G. The beneficial effect of aspirin and enoxaparin on fi-brosis progression and regenerative activity in a rat model of cirrhosis. Dig Dis Sci 2007; 52: 1187-1193.
26. Li W, Zhang J, Huang Q, Zhu H, Zhang X. Long-term administering low anticoagulant activity heparin can lessen rat hepatic fibrosis induced by either CCl4 or porcine serum injection. Hepatol Res 2006; 36: 115-123.
27. Abdel-Salam OME, Baiuomy AR, Ameen A, Hassan NS. A study of unfractionated and low molecular weight heparins in a moel of cholestatic liver injury in the rat. Pharmacol Res 2005; 51:59-67.
28. Shi J, Hao JH, Ren WH, Zhu JR. Effects of heparin on liver fibrosis in patients with chronic hepatitis B. World J Gas-troenterol 2003; 9: 1611-1614.
29. Seval Y, Akkoyunlu G, Demir R, Asar M. Distribution patterns of metalloproteinase (MMP)-2 and-9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem 2004; 106: 353-362.
30. Alison MR, Islam S, Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pa-thol 2009; 217: 282-298.
31. Ramadori I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol pharmacol 2008; 59: 107-117.
32. Sola S, Amaral J, Aranha M, Ster C, Rodrigues C. Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. Curr Med Chem 2006; 13: 3039-3051.
33. Donthamsetty S, Bhave US, Mitra MS, Latendresse JR, Me-hendale HM. Nonalcolic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 2007; 45: 391-403.
34. Zhang LM, Liu DW, Liu JB, Zhang XL, Wang XB, Tang LM, Wang LQ. Effect of naked eukaryotic expression plasmid encoding rat augmenter of liver regeneration on acute hepatic injury and hepatic failure in rats. World J Gas-troenterol 2005; 11: 3680-3685.
35. Neubauer K, Saile B, Ramadori G. Liver fibrosis and altered matrix synthesis. Can J Gastroenterol 2001; 15: 187-193.
36. Kikkawa Y, Mochizuki Y, Miner JM, Mitaka T. Transient expression of laminin α1 chain in regenerating murine liver; restricted localization of laminin chains and nidogen-1. Exp Cell Res 2005; 305: 99-109.
37. Yuan TX, Zhang JS, Zhang YE, Chen Q. Culture of rat liver Ito cells and the observation of inhibitory effect of heparin on Ito cells. Shanghai Yýke Daxeu Xuebao 1996; 23: 90-93.
38. Harada N, Okajima K, Uchiba M. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. Crit Care Med 2006; 34: 1883-1891.